The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R
Authors:
- 30 November 1989
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 63 (12) , 5276-5284
Abstract
From the cloning and characterization of cDNAs, we found that the Epstein-Barr virus (DBV) open reading frame (ORF) BMLF1-BSLF2 coding for the early protein EB2 is present in several mRNAS generated by alternative splicing and expressed in the leftward direction from two promoters PM and PM1. The PM promoter controls the expression of two abundant mRNA species of 1.9 and 2 kilobases (kb), whereas the PM1 promoter controls the expression of at least three mRNAs 3.6, 4.0, and 4.4 kb long. The PM promoter probably overlaps with the PS promoter which controls the transcription of a 3.6-kb mRNA expressed in the rightward direction and containing the ORF barf1. Although it increases the amount of chloramphenicol acetyltransferase enzyme expressed from the chimeric pMCAT gene, EB2 is not promiscuous trans-activator of gene expression and dose not positively regulate its own expression from promoter PM. The EB2 activation is not promoter dependent but could possibly act by stabilizing mRNAs and increasing their translation. The PM promoter is, however, activated by the two EBV transcription trans-acting factors, EB1 and R, encoded by the EBV ORFs BZLF1 and BRLF1, respectively. EB1 activates the PM promoter from a consensus AP-1 binding site, and R activates the PM promoter from an enhancer.Keywords
This publication has 32 references indexed in Scilit:
- The oncogene jun and nuclear signallingTrends in Biochemical Sciences, 1989
- Characterization of proteins encoded by the epstein-barr virus transactivator gene BMLF1Virology, 1989
- Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virusCell, 1988
- An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.Proceedings of the National Academy of Sciences, 1988
- Human Proto-Oncogene c- jun Encodes a DNA Binding Protein with Structural and Functional Properties of Transcription Factor AP-1Science, 1987
- Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.Proceedings of the National Academy of Sciences, 1985
- DNA sequence and expression of the B95-8 Epstein—Barr virus genomeNature, 1984
- Non-contiguous segments of the polyoma genome required in cis for DNA replicationJournal of Molecular Biology, 1982
- Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donorCell, 1978
- Persisting oncogenic herpesvirus induced by the tumour promoter TPANature, 1978